Company Profile

Spriaso is a biopharmaceutical company dedicated to improving therapeutics through innovative patient friendly product options. Spriaso has several candidates in development with a focus on the central nervous system (CNS) and gastrointestinal (GI) disorders. Our portfolio of unique products have successfully completed proof of principle clinical studies and are expected to proceed to NDA filing in the near term. These products are available for out-license to a marketing partner and are protected by multiple issued and pending patents.

Contact us for more information about our pipeline products and licensing opportunities.